The Provider Score for the Lung Cancer Score in 18013, Bangor, Pennsylvania is 69 when comparing 34,000 ZIP Codes in the United States.
An estimate of 96.17 percent of the residents in 18013 has some form of health insurance. 39.05 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 72.89 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 18013 have VA health insurance. Also, percent of the residents receive TRICARE.
For the 4,260 residents under the age of 18, there is an estimate of 17 pediatricians in a 20-mile radius of 18013. An estimate of 56 geriatricians or physicians who focus on the elderly who can serve the 3,184 residents over the age of 65 years.
In a 20-mile radius, there are 13,964 health care providers accessible to residents in 18013, Bangor, Pennsylvania.
Health Scores in 18013, Bangor, Pennsylvania
Lung Cancer Score | 59 |
---|---|
People Score | 21 |
Provider Score | 69 |
Hospital Score | 53 |
Travel Score | 62 |
18013 | Bangor | Pennsylvania | |
---|---|---|---|
Providers per 10,000 residents | 0.00 | 0.00 | 0.00 |
Pediatricians per 10,000 residents under 18 | 0.00 | 0.00 | 0.00 |
Geriatricians per 10,000 residents over 65 | 0.00 | 0.00 | 0.00 |
## Lung Cancer Score Analysis: Bangor, PA (ZIP Code 18013)
This analysis delves into the landscape of lung cancer care within Bangor, Pennsylvania (ZIP Code 18013), focusing on the availability and quality of primary care services, a crucial element in early detection and management. We will evaluate the local physician network, telemedicine integration, and mental health support, ultimately providing a Lung Cancer Score assessment.
The foundation of effective lung cancer care lies in proactive primary care. Early detection through regular screenings, facilitated by a strong patient-physician relationship, significantly improves survival rates. Therefore, the availability of primary care physicians (PCPs) and the ease of accessing their services are paramount. In Bangor, the physician-to-patient ratio serves as a key indicator. Analyzing this ratio reveals the potential for patient access. A low ratio, indicating fewer patients per physician, generally translates to shorter wait times for appointments and more personalized care. Conversely, a high ratio might indicate challenges in accessing timely care, potentially delaying crucial screenings and interventions.
Bangor's primary care landscape requires a granular examination. Are there sufficient PCPs to meet the needs of the community? Are specialists, such as pulmonologists and oncologists, readily available within a reasonable travel distance? The presence of these specialists, along with their ability to collaborate effectively with PCPs, forms a vital network. This collaborative approach ensures seamless transitions for patients, from initial screening and diagnosis to treatment and ongoing management. The Lung Cancer Score will consider the geographical distribution of specialists, the ease of referral processes, and the overall coordination of care.
Several practices in the 18013 ZIP code might stand out based on their commitment to lung cancer prevention and treatment. These standout practices often prioritize patient education, offering resources on smoking cessation, healthy lifestyle choices, and the importance of regular screenings. They might also employ advanced diagnostic technologies, such as low-dose CT scans, to detect lung cancer at its earliest stages. Further, these practices may have established robust follow-up programs to monitor patients post-treatment. Identifying these leading practices will be a crucial element in the Lung Cancer Score.
Telemedicine has emerged as a valuable tool in healthcare, particularly in rural or underserved areas. The adoption of telemedicine by primary care practices in Bangor is a critical factor. Telemedicine can facilitate virtual consultations, allowing patients to connect with their physicians remotely, thereby reducing travel burdens and improving access to care, especially for those with mobility issues or living in geographically isolated areas. Furthermore, telemedicine can enable remote monitoring of patients, allowing for early detection of complications and proactive interventions. The Lung Cancer Score will assess the extent of telemedicine integration, including the availability of virtual appointments, remote monitoring capabilities, and the overall user-friendliness of the telemedicine platforms.
The emotional toll of a lung cancer diagnosis and treatment is significant. Therefore, the availability of mental health resources is an integral part of comprehensive care. Primary care practices should ideally have access to mental health professionals or be able to readily refer patients to these services. This support can help patients cope with the psychological challenges associated with the disease, including anxiety, depression, and fear. The Lung Cancer Score will evaluate the availability of mental health resources, including the presence of on-site counselors, referral pathways to mental health specialists, and the integration of mental health services into the overall care plan.
The Lung Cancer Score will also consider the presence of support groups and educational programs for patients and their families. These resources provide a platform for patients to connect with others facing similar challenges, share experiences, and receive emotional support. Educational programs empower patients with knowledge about their disease, treatment options, and self-management strategies. The availability and accessibility of these resources will contribute to the overall score.
The analysis should also include an assessment of the quality of care provided by the local hospitals and treatment centers. This includes evaluating their accreditation status, the expertise of their medical staff, and their access to advanced treatment modalities, such as radiation therapy and chemotherapy. The Lung Cancer Score will incorporate data on patient outcomes, such as survival rates and complication rates, to provide a comprehensive evaluation of the quality of care.
The final Lung Cancer Score for Bangor (18013) will be a composite metric, reflecting the combined assessment of all the factors discussed above. This score will provide a valuable benchmark for the community, highlighting areas of strength and areas that require improvement. The score will be dynamic, allowing for continuous monitoring of progress and the identification of opportunities to enhance lung cancer care.
Ultimately, the goal is to provide a clear picture of the current landscape of lung cancer care in Bangor, PA (18013). The analysis will aim to identify the strengths and weaknesses of the local healthcare system, providing insights for both patients and healthcare providers. By understanding the current state of care, the community can work together to improve access, quality, and outcomes for individuals affected by lung cancer.
For a visual representation of the data, including physician locations, specialist availability, and access to healthcare facilities, explore the dynamic and interactive mapping capabilities offered by CartoChrome maps. CartoChrome maps provides a powerful platform for visualizing healthcare data, enabling users to gain a deeper understanding of the healthcare landscape in Bangor and beyond.
Reviews
No reviews yet.
You may also like